NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: STAAR Ovarian Cancer Foundation
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Research Grant Awarded for Low-Grade Ovarian Cancer Study - STAAR Ovarian Cancer Foundation to fund biomarkers of sensitivity to aromatase inhibitors research - StaarOC.org
Research Grant Awarded for Low-Grade Ovarian Cancer Study

 

NewswireToday - /newswire/ - Western Springs, IL, United States, 2022/03/22 - STAAR Ovarian Cancer Foundation to fund biomarkers of sensitivity to aromatase inhibitors research - StaarOC.org.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

A new research study at University of Texas MD Anderson Cancer Center funded by STAAR Ovarian Cancer Foundation will determine if biomarkers can identify how aromatase inhibitors influence clinical outcomes of patients with low-grade serous ovarian cancer.

Aromatase inhibitors such as letrozole, anastrozole and exemestane reduce the level of estrogen in the body. They have been found to be effective against low-grade serous ovarian carcinoma (LGSOC), which can be resistant to chemotherapy. There is currently no known biomarker to predict if the patient will benefit from this type of treatment. If this biomarker exists, physicians would be able to use it to assess which patients are likely to benefit from the use of an aromatase inhibitor and which patients will not.

“As a patient that has been on each of the three types of aromatase inhibitors (letrozole, exemestane, and anastrozole) in under a year, a study like this is very exciting,” said Morgan Gaynor, ovarian cancer survivor and Secretary of STAAR Ovarian Cancer Foundation. “These medications can come with debilitating side effects so it can be hard to find one to stick with. Being able to know which treatments will or won’t work for someone is a major incentive towards medication compliance, which leads to better outcomes.”

The study will examine the molecular biology in LGSOC of dozens of women that have recurrent disease and were treated with aromatase inhibitors. Researchers will study tissue from LGSOC patients for gene abnormalities and the proteins expressed.

“We are extremely grateful to STAAR for their generous support of this important research initiative. Low-grade serous ovarian carcinoma is a rare subtype of ovarian cancers that is relatively insensitive to chemotherapy,” said Dr. David Gershenson of University of Texas MD Anderson Cancer Center. “And because we know endocrine therapy can be successful, we need to better understand for whom.”

LGSOC is a rare and extremely underfunded subtype of ovarian cancer, making up fewer than 10% of ovarian cancer cases.

MD Anderson Cancer Center is a world leader in LGSOC research. Doctors there were instrumental in helping identify it as a unique cancer in 2004 and their research has formed the basis for many of the current treatment recommendations. In 2018, they added LGSOC to their Cancer Moon Shots Program.

STAAR Ovarian Cancer Foundation (staaroc.org) is the only US-based nonprofit dedicated to low-grade serous ovarian cancer. It was co-founded by three women with LGSOC in early 2020. The foundation works with the global charity Cure Our Ovarian Cancer to advance research opportunities in the United States to find better treatment options for LGSOC.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: STAAR Ovarian Cancer Foundation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Research Grant Awarded for Low-Grade Ovarian Cancer Study

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Morgan Gaynor - StaarOC.org 
732-895-1199 mgaynor89[.]gmail.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any STAAR Ovarian Cancer Foundation securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From STAAR Ovarian Cancer Foundation / Company Profile


Read Health / Surgery Most Recent Related Newswires:

AGS Health, A Global Leader in Revenue Cycle Management Solutions Establishes Operations in Jaipur, India
Next-generation Diagnostics Paving the Way to Reach Personalized Medicine According to Frost & Sullivan
InterSystems Partners with the Rhodes Group to Improve Hepatitis C Treatment in New Mexico
BostonGene Announces 0 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status
Roche Diagnostics India Earns the Frost & Sullivan 2021 India Competitive Strategy Leadership Award
Wolters Kluwer Lauded by Frost & Sullivan for Enabling Aligned Decision-making with its Clinical Decision Support Solutions
Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery
Lumeon Commended by Frost & Sullivan for Enabling Digital Transformation in Healthcare
Payment Integrity Solutions Enable Healthcare Plans to Optimize Processes and Maximize Returns Finds Frost & Sullivan
Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025 Finds Frost & Sullivan
Innovative MedTech Business Models Will Enable Cost-effective, Decentralized and Patient-centric Care Finds Frost & Sullivan
Data Monetization a Must for MedTech Industry to Evolve Toward Real-World Evidence and Precision Medicine Finds Frost & Sullivan
InterSystems Partners with Cognetivity on Ground-breaking AI Solution for Early Dementia Detection
Humimic Medical, Partners Team Up to Make A Difference in South Carolina COVID Battle
Adoption of HaH Model Surged Eight-fold with the Availability of Advanced Remote Monitoring and Digital Health Solutions Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)